These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36777301)

  • 1. Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients.
    Benson MJ; Abelev SV; Connor SJ; Corte CJ; Martin LJ; Gold LK; Suraev AS; McGregor IS
    Crohns Colitis 360; 2020 Apr; 2(2):otaa015. PubMed ID: 36777301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease.
    Benson MJ; Abelev SV; Corte CJ; Connor SJ; McGregor IS
    Crohns Colitis 360; 2020 Apr; 2(2):otaa045. PubMed ID: 36777304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.
    Coates MD; Dalessio S; Walter V; Stuart A; Bernasko N; Tinsley A; Razeghi S; Williams ED; Clarke K; Vrana K
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):445-450. PubMed ID: 33998892
    [No Abstract]   [Full Text] [Related]  

  • 4. Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study.
    Appleton K; Whittaker E; Cohen Z; Rhodes HM; Dunn C; Murphy S; Gaastra M; Galletly A; Dougherty S; Haren A; Sukumaran N; Aluzaite K; Dockerty JD; Turner RM; Schultz M
    N Z Med J; 2021 Feb; 134(1530):38-47. PubMed ID: 33651776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.
    Sinclair J; Toufaili Y; Gock S; Pegorer AG; Wattle J; Franke M; Alzwayid MAKM; Abbott J; Pate DW; Sarris J; Armour M
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):464-472. PubMed ID: 34978929
    [No Abstract]   [Full Text] [Related]  

  • 6. Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.
    Bawa Z; McCartney D; Manocha R; McGregor IS
    BMC Prim Care; 2022 Dec; 23(1):330. PubMed ID: 36529730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey.
    Neufeld T; Pfuhlmann K; Stock-Schröer B; Kairey L; Bauer N; Häuser W; Langhorst J
    Z Gastroenterol; 2021 Oct; 59(10):1068-1077. PubMed ID: 34157755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use amongst patients with inflammatory bowel disease.
    Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease.
    Greywoode R; Cunningham C; Hollins M; Aroniadis O
    J Clin Gastroenterol; 2023 Sep; 57(8):824-829. PubMed ID: 36227025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
    Storr M; Devlin S; Kaplan GG; Panaccione R; Andrews CN
    Inflamm Bowel Dis; 2014 Mar; 20(3):472-80. PubMed ID: 24407485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study.
    Fitzcharles MA; Rampakakis E; Sampalis JS; Shir Y; Cohen M; Starr M; Häuser W
    Clin Exp Rheumatol; 2021; 39 Suppl 130(3):115-119. PubMed ID: 33938797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions and Prevalence of Cannabis Use in Women With Inflammatory Bowel Disease of Reproductive Age: A Cross-Sectional Study.
    Hossein-Javaheri N; O'Connor K; Steinhart H; Deshpande A; Maxwell C; Huang V; Tandon P
    J Can Assoc Gastroenterol; 2024 Apr; 7(2):204-211. PubMed ID: 38596807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.
    Olson RE; Smith A; Good P; Dudley M; Gurgenci T; Hardy J
    Health Expect; 2023 Feb; 26(1):160-171. PubMed ID: 36335552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana use patterns among patients with inflammatory bowel disease.
    Ravikoff Allegretti J; Courtwright A; Lucci M; Korzenik JR; Levine J
    Inflamm Bowel Dis; 2013 Dec; 19(13):2809-14. PubMed ID: 24185313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD).
    Velez-Santiago A; Alvarez-Torres E; Martinez-Rodriguez R; Candal-Rivera E; Muniz-Camacho L; Ramos-Burgos L; Torres EA
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36982049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living With Inflammatory Bowel Disease: Online Surveys Evaluating Patient Perspectives on Treatment Satisfaction and Health-Related Quality of Life.
    Charabaty A; Schneider B; Zambrano JA; Keefer L
    Crohns Colitis 360; 2022 Jul; 4(3):otac035. PubMed ID: 36777425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry.
    Dalavaye N; Erridge S; Nicholas M; Pillai M; Bapir L; Holvey C; Coomber R; Rucker JJ; Hoare J; Sodergren MH
    Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):85-98. PubMed ID: 36562418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.